EVOTEC SE - SPON ADR (EVO:NASDAQ)
$1.95 0.06 (3.1746%)
Analysed EVOTEC SE - SPON ADR (EVO:NASDAQ) News Sources
Evotec Reports Results of the Annual General Meeting 2026
11-06-2026
yahoo.com
Just - Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics
30-06-2026
yahoo.com
Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
13-07-2026
yahoo.com
Evotec Q2 Earnings Call Highlights
14-07-2026
marketbeat.com
Evotec SE (EVO) Q2 2026 Earnings Call Highlights: Navigating Revenue Declines and Strategic ...
14-07-2026
yahoo.com
Evotec and Odyssey Therapeutics Enter AI-Enabled R&D Collaboration in Autoimmune and Inflammatory Diseases
06-08-2026
yahoo.com
Odyssey Therapeutics (ODTX) Looks Fully Valued As Earnings And Evotec Deal Refocus Attention
11-08-2026
yahoo.com
Cell-Based Assay Services for Preclinical Use Only Global Market Report 2026 Released — Profiles Charles River, Labcorp, Eurofins and Evotec
15-07-2026
yahoo.com
Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management
23-07-2026
yahoo.com
Evotec and Odyssey collaborate on AI-enabled R&D
07-08-2026
pharmaceutical-technology.com
What is the current price of EVOTEC SE - SPON ADR (EVO:NASDAQ)?
The current price of EVOTEC SE - SPON ADR (EVO:NASDAQ) is $1.95.
EVOTEC SE - SPON ADR (EVO:NASDAQ) absolute price change since previous trading day?
The absolute price change of EVOTEC SE - SPON ADR (EVO:NASDAQ) since the previous trading day is $0.06.
EVOTEC SE - SPON ADR (EVO:NASDAQ) percentage price change since previous trading day?
The percentage price change of EVOTEC SE - SPON ADR (EVO:NASDAQ) since the previous trading day is 3.1746%.
What is the most recent average sentiment score for EVOTEC SE - SPON ADR (EVO:NASDAQ)?
The most recent average sentiment score for EVOTEC SE - SPON ADR (EVO:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for EVOTEC SE - SPON ADR (EVO:NASDAQ)?
The most recent sentiment for EVOTEC SE - SPON ADR (EVO:NASDAQ) is .
SEC-8K** Filing Available For EVOTEC SE - SPON ADR (EVO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.